Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial

Kirstie Louise Lamb, Anthony Lynn, Jean Russell, Margo E Barker, Kirstie Louise Lamb, Anthony Lynn, Jean Russell, Margo E Barker

Abstract

Introduction: Gout is a painful form of inflammatory arthritis associated with several comorbidities, particularly cardiovascular disease. Cherries, which are rich in anti-inflammatory and antioxidative bioactive compounds, are proposed to be efficacious in preventing and treating gout, but recommendations to patients are conflicting. Cherry consumption has been demonstrated to lower serum urate levels and inflammation in several small studies. One observational case cross-over study reported that cherry consumption was associated with reduced risk of recurrent gout attacks. This preliminary evidence requires substantiation. The proposed randomised clinical trial aims to test the effect of consumption of tart cherry juice on risk of gout attacks.

Methods and analysis: This 12-month, parallel, double-blind, randomised, placebo-controlled trial will recruit 120 individuals (aged 18-80 years) with a clinical diagnosis of gout who have self-reported a gout flare in the previous year. Participants will be randomly assigned to an intervention group, which will receive Montmorency tart cherry juice daily for a 12-month period, or a corresponding placebo group, which will receive a cherry-flavoured placebo drink. The primary study outcome is change in frequency of self-reported gout attacks. Secondary outcome measures include attack intensity, serum urate concentration, fractional excretion of uric acid, biomarkers of inflammation, blood lipids and other markers of cardiovascular risk. Other secondary outcome measures will be changes in physical activity and functional status. Statistical analysis will be conducted on an intention-to-treat basis.

Ethics and dissemination: This study has been granted ethical approval by the National Research Ethics Service, Yorkshire and The Humber-Leeds West Research Ethics Committee (ref: 18/SW/0262). Results of the trial will be submitted for publication in a peer-reviewed journal.

Trial registration number: NCT03621215.

Keywords: gout; musculoskeletal disorders; nutrition & dietetics; rheumatology; tart cherry.

Conflict of interest statement

Competing interests: MEB and AL are the joint recipients of a research grant from the CMI, Michigan, USA.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Participant flow through the study. PA; physical activity.

References

    1. Hui M, Carr A, Cameron S, et al. . The British Society for rheumatology guideline for the management of gout. Rheumatology 2017;56:e1–20. 10.1093/rheumatology/kex156
    1. Kuo C-F, Grainge MJ, Zhang W, et al. . Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015;11:649–62. 10.1038/nrrheum.2015.91
    1. Kuo C-F, Grainge MJ, Mallen C, et al. . Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 2015;74:661–7. 10.1136/annrheumdis-2013-204463
    1. Stack AG, Hanley A, Casserly LF, et al. . Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality. QJM 2013;106:647–58. 10.1093/qjmed/hct083
    1. Kuo C-F, Grainge MJ, Mallen C, et al. . Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis 2016;75:210–7. 10.1136/annrheumdis-2014-206410
    1. Roddy E, Doherty M. Gout. epidemiology of gout. Arthritis Res Ther 2010;12:1–11. 10.1186/ar3199
    1. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet 2016;388:2039–52. 10.1016/S0140-6736(16)00346-9
    1. Roddy E. Revisiting the pathogenesis of podagra: why does gout target the foot? J Foot Ankle Res 2011;4:1–6. 10.1186/1757-1146-4-13
    1. Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 2006;8:S4–9. 10.1186/ar1909
    1. Abhishek A, Doherty M. Education and non-pharmacological approaches for gout. Rheumatology 2018;57:i51–8. 10.1093/rheumatology/kex421
    1. Choi HK, Atkinson K, Karlson EW, et al. . Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277–81. 10.1016/S0140-6736(04)16000-5
    1. Choi JWJ, Ford ES, Gao X, et al. . Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the third National health and nutrition examination survey. Arthritis Rheum 2008;59:109–16. 10.1002/art.23245
    1. Major TJ, Topless RK, Dalbeth N, et al. . Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ 2018;363:1–10. 10.1136/bmj.k3951
    1. Wang M, Jiang X, Wu W, et al. . A meta-analysis of alcohol consumption and the risk of gout. Clin Rheumatol 2013;32:1641–8. 10.1007/s10067-013-2319-y
    1. Wang DD, Sievenpiper JL, de Souza RJ, et al. . The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 2012;142:916–23. 10.3945/jn.111.151951
    1. White SJ, Carran EL, Reynolds AN, et al. . The effects of apples and apple juice on acute plasma uric acid concentration: a randomized controlled trial. Am J Clin Nutr 2018;107:165–72. 10.1093/ajcn/nqx059
    1. Blau LW. Cherry diet control for gout and arthritis. Tex Rep Biol Med 1950;8:309–11.
    1. Bell PG, Gaze DC, Davison GW, et al. . Montmorency tart cherry (Prunus cerasus L.) concentrate lowers uric acid, independent of plasma cyanidin-3-O-glucosiderutinoside. J Funct Foods 2014;11:82–90. 10.1016/j.jff.2014.09.004
    1. Jacob RA, Spinozzi GM, Simon VA, et al. . Consumption of cherries lowers plasma urate in healthy women. J Nutr 2003;133:1826–9. 10.1093/jn/133.6.1826
    1. Martin KR, Coles KM. Consumption of 100% tart cherry juice reduces serum urate in overweight and obese adults. Curr Dev Nutr 2019;3:1–9. 10.1093/cdn/nzz011
    1. Zhang Y, Neogi T, Chen C, et al. . Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum 2012;64:4004–11. 10.1002/art.34677
    1. Schlesinger N, Rabinowitz R, Schlesinger M. Pilot studies of cherry juice concentrate for gout flare prophylaxis. J Arthritis 2012;01:1–5. 10.4172/2167-7921.1000101
    1. Singh JA, Green C, Morgan S, et al. . A randomized Internet-based pilot feasibility and planning study of cherry extract and diet modification in gout. J Clin Rheumatol 2019. 10.1097/RHU.0000000000001004. [Epub ahead of print: 23 Jan 2019].
    1. Kelley DS, Rasooly R, Jacob RA, et al. . Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 2006;136:981–6. 10.1093/jn/136.4.981
    1. Kelley DS, Adkins Y, Reddy A, et al. . Sweet bing cherries lower circulating concentrations of markers for chronic inflammatory diseases in healthy humans. J Nutr 2013;143:340–4. 10.3945/jn.112.171371
    1. Chai SC, Davis K, Zhang Z, et al. . Effects of tart cherry juice on biomarkers of inflammation and oxidative stress in older adults. Nutrients 2019;11:228 10.3390/nu11020228
    1. Kuehl KS, Elliot DL, Sleigh AE, et al. . Efficacy of tart cherry juice to reduce inflammation biomarkers among women with inflammatory osteoarthritis (OA). J Food Stud 2012;1:14–25. 10.5296/jfs.v1i1.1927
    1. Schumacher HR, Pullman-Mooar S, Gupta SR, et al. . Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee. Osteoarthr Cartil 2013;21:1035–41. 10.1016/j.joca.2013.05.009
    1. NICE Clinical knowledge summary: gout, 2018. Available: [Accessed 5 Sep 2019].
    1. Richette P, Doherty M, Pascual E, et al. . 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2017;76:29–42. 10.1136/annrheumdis-2016-209707
    1. Arthritis Research UK Gout, 2016. Available: [Accessed 6 Jun 2019].
    1. Mayo Clinic Gout: diagnosis and treatment, 2019. Available: [Accessed 4 Jun 2019].
    1. UK Gout Society All about gout and diet. Available: [Accessed 9 Feb 2019].
    1. U.S. Food and Drug Administration List of firms receiving warning letters regarding cherry and other fruit-based products with disease claims in labeling, 2005. Available: [Accessed 5 May 2019].
    1. Duyck SD, Petrie KJ, Dalbeth N. “You Don't Have to Be a Drinker to Get Gout, But It Helps”: A Content Analysis of the Depiction of Gout in Popular Newspapers. Arthritis Care Res 2016;68:1721–5. 10.1002/acr.22879
    1. NHS Choices Cherry juice touted as treatment for gout, 2014. Available: [Accessed 17 Jun 2018].
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Caliceti C, Calabria D, Roda A, et al. . Fructose intake, serum uric acid, and cardiometabolic disorders: a critical review. Nutrients 2017;9:395 10.3390/nu9040395
    1. Alvarez-Hernández E, Peláez-Ballestas I, Vázquez-Mellado J, et al. . Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Rheum 2008;59:665–9. 10.1002/art.23575
    1. Dalbeth N, Ames R, Gamble GD, et al. . Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann Rheum Dis 2012;71:929–34. 10.1136/annrheumdis-2011-200156
    1. Rothenbacher D, Primatesta P, Ferreira A, et al. . Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology 2011;50:973–81. 10.1093/rheumatology/keq363

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj